Thrombin topical (Bristol-Myers Squibb)

凝血酶（百时美施贵宝）

Report date: 2022/06/14 20:00:40

Base Information

Drug NameThrombin topical (Bristol-Myers Squibb)
Drug Alias NameThrombin α凝血酶αThrombin alfa (ZymoGenetics)凝血酶阿尔法rhThrombin +[11] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionFibrinogen stimulants
TargetsFibrinogen
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2008/01/17
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeB02BC06B02BD30
Related LinksN/A